Wednesday, April 30, 2014

PharMEDium Launches “I.D. Your I.V.®”


Amy Langan,, 847-457-2327

Molly Watson,, 413-454-3926 
LAKE FOREST, Ill., APRIL 30, 2014— PharMEDium Healthcare Corp., the nation’s leading provider of hospital pharmacy-outsourced, sterile admixture services, launched I.D. Your I.V.® solution today, which includes innovative, U.S.-Patented labeling that helps clinicians easily and quickly confirm the identity of medications to improve administration accuracy and reduce the risk of errors.
I.D. Your I.V.® is more than just a redesigned label, but rather a patient-safety focused solution from PharMEDium that includes the compounded service, its clearVIEW overwrap bag, an all-inclusive bar code for better patient traceability, an easy-to-read dual-labeled bag and IV tubing labels. The labels, a first of their kind, are removed from the back of the bag at the point of administration and folded around the tubing to offer clinicians an additional opportunity to reconfirm the correct medication is being delivered. This solution is easily integrated into medication use workflows and fully supports the “5 rights” of medication administration so the right medication is delivered to the right patient with the right dosage using the right route at the right time.
Responding to the industry
I.D. Your I.V.® is based on input from more than 1,000 critical care nurses, nurse educators, clinical pharmacists, and patient safety professionals responsible for IV therapy. Although the solution is being formally introduced today, PharMEDium began reaching out to its customers earlier this year to inform them of the enhancements and offering educational resources to clinicians to help communicate the changes around their organizations.
“This effort demonstrates PharMEDium’s decade-long understanding of the complex environment where multiple IV medications are used frequently, as well as the company’s continued dedication to providing important tools to clinicians at the point of care,” said Rich Kruzynski, RPh, president, PharMEDium.

No comments: